Breaking News: Inventiva Secures $348 Million in Funding for Groundbreaking NATiV3 Phase 3 MASH Study!
Welcome to the Future of Medicine! Exciting News from Inventiva Daix (France), Long Island City (New York, United States), October 14, 2024 Today, Inventiva, a leading biopharmaceutical company, made a groundbreaking announcement that is set to revolutionize the world of medicine. The Company has secured a significant financing of €94.1 million, with the potential to…